Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
7.39
+0.18 (2.50%)
Oct 9, 2026, 1:24 PM EDT - Market open
MRVI Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,919 | 471 | 773 | 866 | 1,882 | 5,508 | |
Market Cap Growth | 127.05% | -39.03% | -10.72% | -54.00% | -65.83% | 100.45% |
Enterprise Value | 2,067 | 782 | 1,076 | 1,274 | 2,181 | 5,710 |
Last Close Price | 7.21 | 3.25 | 5.45 | 6.55 | 14.31 | 41.90 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | 8.55 | 30.26 |
Forward PE | - | 126.02 | 126.02 | 207.05 | 23.42 | 42.82 |
PS Ratio | 9.12 | 2.54 | 2.98 | 3.00 | 2.13 | 6.89 |
PB Ratio | 5.25 | 1.26 | 1.34 | 1.10 | 2.08 | 10.10 |
P/TBV Ratio | - | - | - | - | 41.94 | 121.96 |
P/FCF Ratio | - | - | - | 14.27 | 3.63 | 15.57 |
P/OCF Ratio | - | - | 103.56 | 6.86 | 3.51 | 14.95 |
PEG Ratio | - | 213.02 | 213.02 | 10.59 | 10.59 | 10.59 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 9.83 | 4.21 | 4.15 | 4.41 | 2.47 | 7.14 |
EV/EBITDA Ratio | - | - | - | 108.09 | 3.62 | 10.05 |
EV/EBIT Ratio | - | - | - | - | 3.83 | 10.51 |
EV/FCF Ratio | - | - | - | 21.00 | 4.20 | 16.14 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.61 | 0.98 | 0.65 | 0.77 | 0.65 | 1.06 |
Debt / EBITDA Ratio | 49.18 | - | - | 18.48 | 0.95 | 0.99 |
Debt / FCF Ratio | - | - | - | 10.07 | 1.13 | 1.63 |
Net Debt / Equity Ratio | 0.42 | 0.40 | 0.09 | 0.05 | -0.05 | 0.04 |
Net Debt / EBITDA Ratio | -7.50 | -1.99 | -2.18 | 3.06 | -0.08 | 0.04 |
Net Debt / FCF Ratio | -4.13 | -2.09 | -2.38 | 0.59 | -0.09 | 0.07 |
Asset Turnover | 0.28 | 0.21 | 0.21 | 0.15 | 0.42 | 0.50 |
Inventory Turnover | 3.05 | 3.31 | 2.97 | 3.15 | 3.57 | 3.31 |
Quick Ratio | 2.64 | 5.40 | 6.36 | 7.21 | 7.07 | 7.13 |
Current Ratio | 4.05 | 6.60 | 7.53 | 8.00 | 7.70 | 7.89 |
Return on Equity (ROE) | -33.05% | -48.59% | -37.98% | -16.33% | 67.65% | 134.05% |
Return on Assets (ROA) | -5.71% | -8.83% | -3.64% | -0.94% | 16.96% | 21.30% |
Return on Invested Capital (ROIC) | -13.41% | -21.84% | -9.98% | 0.76% | 71.03% | 89.01% |
Return on Capital Employed (ROCE) | -12.10% | -17.30% | -7.60% | -2.00% | 26.20% | 29.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -4.07% | -27.75% | -18.74% | -13.75% | 11.70% | 3.31% |
FCF Yield | -1.88% | -15.00% | -2.87% | 7.01% | 27.57% | 6.42% |
Buyback Yield / Dilution | -2.29% | -4.68% | -4.54% | 48.33% | 0.96% | -791.80% |